[1] Villasana, M. and Ochoa, G. (2004), Heuristic design of cancer chemotherapies, IEEE Transactions of Evolutionary Computation, 8, 513–521. [2] Villasana, M. and Radunskaya, A. (2003), A delay differential equation of the model for tumor
growth, Journal of Mathematical Biology, 47, 270–294. [3] Heydari, A., Farahi, M.H. and Heydari, A.A. (2006), Optimal control of treatment of tuberculosis, International Journal of Applied Mathematics, 194, 389-404. [4] Yafia, R. (2006), Dynamics analysis
and limit cycle in a delayed model for tumor growth with quiescence, Nonlinear Analysis: Modeling and Control, 11, 95–110. [5] Cojocaru, L. and Agur, Z. (1992), A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs, Math. Biosci., 109, 85–97. [6] Panetta, J.C. and Adam, J. (1995), A mathematical model of cyclespecific chemotherapy, Math. Comput. Modeling, 22(2), 67–82. [7] Birkhead, B.G., Rakin, E.M., Gallivan, S., Dones, L. and Rubens, R.D. (1987), A mathematical model of the development of drug resistance to cancer chemotherapy, European Journal of Cancer and Clinical Oncology, 23(9), 1421-1427. [8] Webb, G.F. (1992), A cell population model of periodic chemotherapy treatment, Biomedical Modelling and Simulation, 83-92. [9] Villasana, M. and Radunskaya, A. (2003), A delay differential equation model for tumor growth, Journal of Mathematical Biology, 47, 270-294. [10] Villasana, M. (2001), A delay differential equation model for tumor growth, Ph.D.
dissertation, Claremont University, United State of America. [11] Ghaffari, A. and Nasserifar, N. (2009), Mathematical modeling and Lyapunov based drug administration in cancer chemotherapy, Iranian Journal of Electronical and Electrical Engineering, 5(3), 151-158. [12] Ghaffari, A., Azizi, K. and Amini, M.R. (2011), Mathematical modelling of Cancer and designing of an optimal
Lyapunov-Based Chemotherapy, Journal of Isfahan Medical School (JIMS) (In Press). [13] Khalil, H.K. (2002), Nonlinear Systems, 3 rd edition, Prentice-Hall, New York.
)